Treatment of ruptured hepatocellular carcinoma

被引:67
|
作者
Tanaka A. [1 ]
Takeda R. [2 ]
Mukaihara S. [2 ]
Hayakawa K. [3 ]
Shibata T. [4 ]
Itoh K. [4 ]
Nishida N. [5 ]
Nakao K. [5 ]
Fukuda Y. [6 ]
Chiba T. [7 ]
Yamaoka Y. [8 ]
机构
[1] Department of Emergency Medicine, Kyoto University Hospital, Sakyo-ku, Kyoto 606-8507
[2] Department of Surgery, Kyoto City Hospital, Kyoto
[3] Department of Radiology, Kyoto City Hospital, Kyoto
[4] Department of Radiology, Graduate School of Medicine, Kyoto University, Kyoto
[5] Second Department of Internal Medicine, Graduate School of Medicine, Kyoto University, Kyoto
[6] Medical Technology College, Kyoto University, Kyoto
[7] Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto
[8] Department of Gastrointestinal Surgery, Graduate School of Medicine, Kyoto University, Kyoto
关键词
Hepatocellular carcinoma; Liver cirrhosis; Shock; Spontaneous rupture; Transcatheter arterial embolization;
D O I
10.1007/s10147-001-8030-z
中图分类号
学科分类号
摘要
Background. The problem of whether surgical or conservative treatment is indicated for ruptured hepatocellular carcinoma (HCC) has not been analyzed from the viewpoint of long-term development of hepatitis viral infection from liver fibrosis to liver cirrhosis. Although transcatheter arterial embolization (TAE) for hemostasis followed by two-stage hepatectomy has been established as the best treatment for ruptured HCC, there still remain difficulties in the treatment of some patients. Methods. Twelve patients with ruptured HCC who were surgically or conservatively treated were retrospectively analyzed in terms of modality of treatment, liver function, extension of HCC, complications, survival rate, and cause of death. Results. Tumor rupture can occur either in the early phase or in the terminal phase during the development from liver fibrosis to liver cirrhosis, while tumor rupture occurs at the advanced stage in terms of HCC extension. TAE for emergent hemostasis or prevention of re-bleeding was performed in ten patients, while TAE was contraindicated in one patient and emergent laparotomy for hemostasis was performed in one patient. In four patients, elective extended surgical resection was performed, because liver function was evaluated as clinical stage 1 according to the General rules for the clinical and pathological study of primary liver cancer of the Liver Cancer Study Group of Japan. In seven patients, conservative or medical treatment was selected, because liver function was evaluated as poor. The surgically treated group, who could tolerate extensive operation, survived longer than the conservatively treated group. Conclusions. While TAE remains the best method to employ for hemostasis, it still has limitations. Hence, we should be mindful of other possible modalities for hemostasis and their outcomes. Rupture of HCC at an early phase in the development of liver fibrosis is a good indication for elective surgical treatment and should be distinguished from rupture in the terminal phase of liver cirrhosis, which should be treated conservatively. Although elective surgical treatment can be performed in selected patients, tumor size and location of HCC, in addition to liver function, should be taken into consideration.
引用
收藏
页码:291 / 295
页数:4
相关论文
共 50 条
  • [1] Treatment of spontaneous ruptured hepatocellular carcinoma
    Yoshida, H
    Onda, M
    Tajiri, T
    Umehara, M
    Mamada, Y
    Matsumoto, S
    Yamamoto, K
    Kaneko, M
    Kumazaki, T
    [J]. HEPATO-GASTROENTEROLOGY, 1999, 46 (28) : 2451 - 2453
  • [2] Ruptured hepatocellular carcinoma
    Meshikhes, AWN
    Wani, HU
    Tinguria, M
    [J]. ANNALS OF SAUDI MEDICINE, 1998, 18 (05) : 476 - 478
  • [3] Outcomes of emergency treatment in ruptured hepatocellular carcinoma in the ED
    Chen, WK
    Chang, YT
    Chung, YT
    Yang, HR
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2005, 23 (06): : 730 - 736
  • [4] Spontaneous ruptured hepatocellular carcinoma
    Yoshida, Hiroshi
    Mamada, Yasuhiro
    Taniai, Nobuhiko
    Uchida, Eiji
    [J]. HEPATOLOGY RESEARCH, 2016, 46 (01) : 13 - 21
  • [5] TRANSCATHETER ARTERIAL EMBOLIZATION FOR THE TREATMENT OF RUPTURED HEPATOCELLULAR-CARCINOMA
    SHIINA, S
    IBUKURO, K
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1989, 153 (03) : 658 - 659
  • [6] Treatment of spontaneous ruptured hepatocellular carcinoma: A single-center study
    Yang, Hanteng
    Chen, Kefei
    Wei, Yongang
    Liu, Fei
    Li, Hongyu
    Zhou, Zhipeng
    Li, Bo
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2014, 30 (03) : 472 - 476
  • [7] Prognosis and therapy for ruptured hepatocellular carcinoma: Problems with staging and treatment strategy
    Hiraoka, Atsushi
    Kawamura, Tomoe
    Aibiki, Toshihiko
    Okudaira, Tomonari
    Toshimori, Akiko
    Yamago, Hiroka
    Nakahara, Hiromasa
    Suga, Yoshifumi
    Azemoto, Nobuaki
    Miyata, Hideki
    Miyamoto, Yasunao
    Ninomiya, Tomoyuki
    Murakami, Tadashi
    Ishimaru, Yoshihiro
    Kawasaki, Hideki
    Hirooka, Masashi
    Abe, Masanori
    Matsuura, Bunzo
    Hiasa, Yoichi
    Michitaka, Kojiro
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (03) : 366 - 371
  • [8] Ruptured hepatocellular carcinoma in cirrhotic patients: Treatment options and survival outcome
    Christodoulidis, G.
    Dimas, D.
    Constantinidis, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S265 - S265
  • [9] Curative treatment for recurrent tumour implantation after ruptured hepatocellular carcinoma
    Chow, Kelvin C. W.
    Tang, C. N.
    Lai, Eric C. H.
    Li, Michael K. W.
    [J]. HONG KONG MEDICAL JOURNAL, 2013, 19 (01) : 82 - 84
  • [10] SPONTANEOUS RUPTURED HEPATOCELLULAR-CARCINOMA - AN APPRAISAL OF SURGICAL-TREATMENT
    LAI, ECS
    WU, KM
    CHOI, TK
    FAN, ST
    WONG, J
    [J]. ANNALS OF SURGERY, 1989, 210 (01) : 24 - 28